Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ALNY Alnylam Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $239.56 -2.4% | $15.06 -2.0% |
| StockIQ Score | 52C- Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 19F | 13F |
| Fundamental | 71B | 35F |
| Growth | 82A- | 50C- |
| Fair Value | 33F | 38F |
| News | 80A- | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Alnylam Pharmaceuticals (ALNY) outperforms Ascentage Pharma (AAPG) in nearly every category. ALNY has a stronger investor score (64 vs. 38), higher technical (68 vs. 19), fundamental (71 vs. 35), and growth scores (82 vs. 50), along with a moderate rating. AAPG’s valuation score (38) is slightly better than ALNY’s (33), but ALNY’s overall scores indicate a more robust performance.